News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No articles were provided for the past hour; no market-moving headlines to summarize.
  • Global markets showed no notable news-driven moves during the past hour.
  • No major economic data releases or central bank comments were published in the hour.
  • No geopolitical or political developments reported in the last hour that would affect risk sentiment.
  • With no fresh headlines, trading volumes and volatility were subdued across key markets.
  • Overall, absence of new information points to a neutral hourly outlook until further updates arrive.

Latest Articles

Canada's industrial producer prices climb in July, led by energy and metals

Canada's industrial producer prices climb in July, led by energy and metals

Statistics Canada reported a 0.6% rise in industrial producer prices in July versus June, reversing a 1.4% drop the prior month. The monthly gain was driven by higher energy and petroleum product prices and increases in primary non-ferrous metals. On an annual basis, industrial product prices were up 12.4%, unchanged from June.

Polyrizon Completes Clinical Site Network for NASARIX™ Study and Advances Toward Patient Enrollment

Polyrizon Completes Clinical Site Network for NASARIX™ Study and Advances Toward Patient Enrollment

Polyrizon Ltd., a biotech company specializing in nasal hydrogel technology, announced completion of contracts with five U.S. clinical sites for its NASARIX™ Allergy Blocker study. The multi-center, randomized trial aims to enroll 120 patients with seasonal allergic rhinitis to evaluate NASARIX's safety, efficacy, and tolerability. With full site p…

Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term

Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term

Cosmos Health Inc. has secured an exclusive five-year distribution agreement with Innova Healthcare in Saudi Arabia for its Sky Premium Life range of nutraceuticals. The deal includes an initial purchase order of 126,000 units and anticipates over 5 million units to be ordered over the term, leveraging Innova's network of 250+ pharmacies and retail…

Singularity Future Technology Ltd. Announces Pricing of $5.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Singularity Future Technology Ltd. Announces Pricing of $5.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Singularity Future Technology Ltd. has priced a $5.0 million registered direct offering of 1,562,500 shares (or pre-funded warrants) at $3.20 per share under Nasdaq rules. The capital raised is intended to support the company's planned data center business expansion. The offering is expected to close by August 21, 2026, subject to customary conditi…

ASML Is Pricier Than It Looks, But Fair for a Monopoly on EUV

ASML Is Pricier Than It Looks, But Fair for a Monopoly on EUV

ASML sits virtually alone in extreme ultraviolet (EUV) lithography and commands pricing power that justifies a premium multiple. At $1,749, the stock is not dirt cheap, but it is reasonably priced for a company with near-monopoly technology, strong cash generation and a central role in the AI-driven capex cycle. This trade idea lays out a disciplin…

Daly Says Treasury Market Signals Policy Is Well-Calibrated

Daly Says Treasury Market Signals Policy Is Well-Calibrated

Federal Reserve Bank of San Francisco President Mary Daly said Treasury market activity suggests monetary policy is appropriately positioned. She rejected concerns about the Fed's credibility and saw little urgency for preemptive rate moves. Recent selling in longer-dated Treasuries pushed 30-year yields to levels not seen since 2007, while a Treas…

Debt Strain Across the G7: Rising Costs and Shrinking Cushions

Debt Strain Across the G7: Rising Costs and Shrinking Cushions

U.S. federal debt has exceeded $40 trillion for the first time, while long-term government borrowing costs in the United States, Japan and parts of Europe are at multi-year highs. Aging populations, defence and climate-related spending, plus shifts in investor demand, are raising interest bills and pressuring fiscal policy across the Group of Seven…

Azio AI Holdings Announces Atlas One, a 500+ Acre Site Designed for Up to 500 MW of Behind‐the‐Meter Power

Azio AI Holdings Announces Atlas One, a 500+ Acre Site Designed for Up to 500 MW of Behind‐the‐Meter Power

Azio AI Holdings announced the launch of Atlas One, the first development phase of Project Atlas, a large-scale compute infrastructure campus in South Texas engineered for up to 500 MW of behind-the-meter natural gas power capacity. Atlas One consolidates owned land, power generation, connectivity, and compute infrastructure to support AI and high-…

HPE: Buy the Networking-Led AI Re-Rating — Tactical Swing Long

HPE: Buy the Networking-Led AI Re-Rating — Tactical Swing Long

HPE has quietly become a top pick for networking-driven, on-premises AI infrastructure. Backlog strength, an expanded product stack after the Juniper integration, and healthy cash flow create a setup for a swing trade. Valuation is no bargain, but the market is pricing in rapid growth; a disciplined entry, stop and target give asymmetric upside whi…

Hovnanian Enterprises Reports Fiscal 2026 Third Quarter Results

Hovnanian Enterprises Reports Fiscal 2026 Third Quarter Results

Hovnanian Enterprises, Inc., a leading U.S. homebuilder, announced its fiscal third quarter and nine months ended July 31, 2026, earnings. The company met or exceeded guidance on most metrics, showing sequential improvement in gross margins for the second consecutive quarter, a 5% year-over-year increase in consolidated domestic backlog value, and …

Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning

Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning

Creative Medical Technology Holdings has successfully completed enrollment and treatment across all cohorts of its FDA-cleared ADAPT clinical trial evaluating CELZ-201 (Olastrocel), a cell therapy for chronic lower back pain. With positive safety and early efficacy signals, the company is transitioning to follow-up, data analysis, and regulatory pr…

Sypris Shares Climb After Win to Produce Satellite Power Units

Sypris Shares Climb After Win to Produce Satellite Power Units

Sypris Solutions Inc saw its stock rise 4.6% in premarket trading following an announcement that its subsidiary, Sypris Electronics, secured a contract to engineer, procure materials for, and mass-produce power processing units for a next-generation satellite constellation. The program includes protoflight and pilot builds beginning in the third qu…